https://nonabio.com/biologics-blog/ 2026-06-12T21:46:54+00:00 https://nonabio.com/biologics-blog/high-concentration-biologics-integrating-developability-to-de-risk-cmc-pathways/ 2026-06-07T04:15:47+00:00 https://nonabio.com/wp-content/uploads/2026/06/High_Concentration-Biologics_Integrating-Developability-to-De_Risk-CMC-Pathways.png https://nonabio.com/wp-content/uploads/2026/06/Solubility-Aggregation-and-Viscosity-Comparison.png https://nonabio.com/wp-content/uploads/2026/06/Liquid-vs.-Lyophilized-DP.png https://nonabio.com/biologics-blog/t-cell-engagers-taking-a-bite-of-pharmas-apple/ 2026-06-11T14:56:15+00:00 https://nonabio.com/wp-content/uploads/2024/09/T-Cell-Engagers-Taking-a-BiTE-of-Pharmas-Apple.png https://nonabio.com/biologics-blog/turning-cancer-inside-out-how-tcr-mimic-antibodies-unmask-cancers-hidden-intracellular-targets/ 2026-06-11T15:11:41+00:00 https://nonabio.com/wp-content/uploads/2025/03/cancer-cell-tcrm-pic.jpg https://nonabio.com/biologics-blog/nona-innovation-forum-2025-an-evening-of-insight-science-strategy-on-boston-harbor/ 2026-06-11T15:18:19+00:00 https://nonabio.com/wp-content/uploads/2025/07/Appreciation-scaled.jpg https://nonabio.com/wp-content/uploads/2025/07/DSC_7593-scaled.jpg https://nonabio.com/wp-content/uploads/2025/07/Jingsong_Speaker-scaled.jpg https://nonabio.com/wp-content/uploads/2025/07/Opening-Remarks-scaled.jpg https://nonabio.com/wp-content/uploads/2025/07/Rizwan_Speaker-scaled.jpg https://nonabio.com/wp-content/uploads/2025/07/Andy_Speaker-scaled.jpg https://nonabio.com/wp-content/uploads/2025/07/Hawa_Henrietta_Speaker-scaled.jpg https://nonabio.com/wp-content/uploads/2025/07/Erwei_Spearker-scaled.jpg https://nonabio.com/biologics-blog/car-t-cell-therapy-in-2025-breakthroughs-barriers-and-the-road-ahead/ 2026-06-11T17:43:22+00:00 https://nonabio.com/wp-content/uploads/2025/08/Blog-Image.jpg https://nonabio.com/biologics-blog/antibody-drug-conjugates-adcs-in-focus-advancements-in-breast-cancer-and-optimization-challenges/ 2026-06-11T17:46:24+00:00 https://nonabio.com/wp-content/uploads/2025/10/ADC-banner_nona.png https://nonabio.com/wp-content/uploads/2025/10/Breast-Cancer-Stats-10162025-scaled.png https://nonabio.com/biologics-blog/car-optimization-for-solid-tumors-with-functional-screening-of-extracellular-domains-ecds/ 2026-06-11T17:55:10+00:00 https://nonabio.com/wp-content/uploads/2025/11/CAR-screening-Nona-1.png https://nonabio.com/wp-content/uploads/2025/11/CAR-Components.png https://nonabio.com/biologics-blog/at-the-forefront-of-next-generation-biotherapeutics-with-fully-human-single-variable-heavy-vh-domains/ 2026-06-11T18:02:07+00:00 https://nonabio.com/wp-content/uploads/2025/12/banner-white-paper-Nona-2.png https://nonabio.com/biologics-blog/from-ex-vivo-to-in-vivo-stepping-into-the-next-chapter-of-car-t-cell-therapy/ 2026-06-11T18:07:54+00:00 https://nonabio.com/wp-content/uploads/2026/01/Blog_Stepping-into-the-Next-Chapter-of-CAR-T-Cell-Therapy-1.png https://nonabio.com/wp-content/uploads/2026/01/Ex-vivo-CAR-T-Workflow.png https://nonabio.com/wp-content/uploads/2026/01/LNP-Delivery-Capability-Nona-Biosciences.png https://nonabio.com/biologics-blog/from-first-to-next-generation-the-evolution-of-harbour-mice-and-fully-human-antibody-discovery/ 2026-06-12T15:23:43+00:00 https://nonabio.com/wp-content/uploads/2024/03/Screenshot-2024-03-05-131926.png https://nonabio.com/biologics-blog/evolving-adcs-through-emerging-payloads-and-linkers/ 2026-06-12T15:32:55+00:00 https://nonabio.com/wp-content/uploads/2026/02/Banner-Evolving-ADCs-through-Emerging-Payloads-and-Linkers.png https://nonabio.com/wp-content/uploads/2026/02/ADC-payload-MOAs-cancers-02082026-scaled.webp https://nonabio.com/biologics-blog/car-t-cells-in-autoimmune-diseases-a-new-therapeutic-frontier/ 2026-06-12T15:35:57+00:00 https://nonabio.com/wp-content/uploads/2026/03/Blog-CAR-T-Cells-in-Autoimmune-Diseases.png https://nonabio.com/wp-content/uploads/2026/03/Autoimmune-Disease-Prevalence-and-Disparity-03_22_26.png https://nonabio.com/biologics-blog/humatrix-applying-ai-where-it-matters-in-antibody-discovery/ 2026-06-12T15:44:52+00:00 https://nonabio.com/wp-content/uploads/2026/04/blog-Hu-mAtrIX_Applying-AI-Where-It-Matters-in-Antibody-Discovery.png https://nonabio.com/wp-content/uploads/2026/04/Ab-Discovery-and-AI.png https://nonabio.com/wp-content/uploads/2026/03/Smarter-Lead-Selection-with-Hu-mAtrIX-1.png https://nonabio.com/biologics-blog/early-cmc-and-toxicology-decisions-that-determine-ind-success-for-next-generation-antibodies/ 2026-06-12T15:49:15+00:00 https://nonabio.com/wp-content/uploads/2026/05/Blog_Early-CMC-and-Toxicology-Decisions-That-Determine-IND-Success-for-Next-Generation-Antibodies.png https://nonabio.com/biologics-blog/first-nona-innovation-day/ 2026-06-12T16:17:59+00:00 https://nonabio.com/wp-content/uploads/2024/02/IMG_5935.jpeg https://nonabio.com/biologics-blog/pegs-europe-recap-nona-biosciences/ 2026-06-12T16:47:28+00:00 https://nonabio.com/wp-content/uploads/2024/01/Screenshot-2024-02-28-162858.png https://nonabio.com/biologics-blog/next-generation-blood-brain-barrier-shuttles-for-neurological-disease/ 2026-06-12T21:46:43+00:00 https://nonabio.com/wp-content/uploads/2026/06/blog_Next-Generation-Blood-Brain-Barrier-Shuttles-for-Neurological-Disease.png https://nonabio.com/wp-content/uploads/2026/06/TFR1-for-BBB-Transfer.png https://nonabio.com/wp-content/uploads/2026/06/Nona-TfR1-shuttle.png https://nonabio.com/wp-content/uploads/2026/06/Nona-TfR1-Shuttle-Transfer-Data.png https://nonabio.com/biologics-blog/targeted-delivery-strategies-for-in-vivo-car-t-cell-generation/ 2026-06-12T21:46:54+00:00 https://nonabio.com/wp-content/uploads/2026/06/Precision-Targeting-in-In-Vivo-CAR-T_From-Concept-to-Strategy.png https://nonabio.com/wp-content/uploads/2026/06/Viral-Non-viral-Vectors.png https://nonabio.com/wp-content/uploads/2026/06/In-Vivo-Data.png